Low glucose metabolism in hepatocellular carcinoma with GPC3 expression.

about

Low glucose metabolism in hepatocellular carcinoma with GPC3 expression.

Item

http://www.wikidata.org/entity/Q49254379

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Low glucose metabolism in hepatocellular carcinoma with GPC3 expression.

@en

Low glucose metabolism in hepatocellular carcinoma with GPC3 expression.

@nl

type

Item

label

Low glucose metabolism in hepatocellular carcinoma with GPC3 expression.

@en

Low glucose metabolism in hepatocellular carcinoma with GPC3 expression.

@nl

prefLabel

Low glucose metabolism in hepatocellular carcinoma with GPC3 expression.

@en

Low glucose metabolism in hepatocellular carcinoma with GPC3 expression.

@nl

P1476

Low glucose metabolism in hepatocellular carcinoma with GPC3 expression.

@en

P2093

Chuan-Sheng Yang

http://www.w3.org/2001/XMLSchema#string

Hong-Sheng Li

http://www.w3.org/2001/XMLSchema#string

Hu-Bing Wu

http://www.w3.org/2001/XMLSchema#string

Quan-Shi Wang

http://www.w3.org/2001/XMLSchema#string

Wen-Lan Zhou

http://www.w3.org/2001/XMLSchema#string

Yan-Jiang Han

http://www.w3.org/2001/XMLSchema#string

You-Cai Li

http://www.w3.org/2001/XMLSchema#string

P2860

Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma

Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer

Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increased (18)F-FDG uptake.

Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy.

Positron emission tomography scanning in the evaluation of hepatocellular carcinoma.

Glypican-3-targeted 89Zr PET imaging of hepatocellular carcinoma.

Hepatocellular carcinoma: the need for progress.

Glypican-3-targeting F(ab')2 for 89Zr PET of hepatocellular carcinoma.

Glucose transporters: expression, regulation and cancer.

The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.

P304

494-503

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V24.I4.494

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29398870

http://www.w3.org/2001/XMLSchema#string

P932

5787784

http://www.w3.org/2001/XMLSchema#string